..2510

... .. 2510

- - - -

- - -

- - -

()- - -

- -

- - - - ,corticosteriod, clofibrate, dipyrone, ARVs ,cisapride, misoprostol ,neuromuscular blocking agents, ...

- - - , , ARVS , ABO, ..- : , Penicillin V potassium dry syrup 5 . . 2

1.Dextromethorphan HBr 12 mg. 4 10 2.HCTZ 50 mg. 4 10 3.Ethinylestradiol 0.03-0.05 mg or Mestranol 0.03-0.05 mg. + Norgestrel 0.25-0.5 mg.or Levonorgestrel 0.125-0.25 mgor Norethisterone1.0-2.5 mgor Lynestrenol 1.0-2.5 mg

()4. CPM 2 mg 4 20 5.Paracetamol 300 - 500 mg + CPM 1-2 mg 4 10 6. Aminophylline 100 mg 4 7. Theophylline anhydrous 60-150 mg+ Ephedrine HCL15-50 mg 4 8. Co-trimoxazole 400+80 mg 4 10 9. Phthalysulphathiazole 500 mg 4 20

11. Mebendazole 100 mg or Mebendazole 500 mg per tablet 6 10 12.Dimenhydrinate 50 mg. 4 10 13. Sulphadoxine 500 mg + Pyrimethamine 25 mg 4 10 ()10. Penicillin V Potassium equivalent to Penicillin V 200,000 units 60 ml

-, , , , , , , , , , ,

1. 2. 3. 4.

- - - - - -

- 30 - - ()

4 1. 2. 3. 4.

(. 15) 6 (1) (2) (3) (4) (5) (6)

(1) (2) (3)

(1) (2) (3) (4)

(5) (6) () () () () (7)

(8) (9) ()

(.25) (1) (2) (3) (4) (5) (6) (7)

(. 26)(1) (2) (3) (4) (5) (6) (7) (8) -

26 (4) 26

26

( 27) (1) (2) (3) (4) (5) (6)

(1) (2) (3) (4) (5) (6) (7)

(8) (9) (10) (11) 76 (7) (8) , (1) (4) (11)

( 46) ( 47) (1.) (2.) 76 (1)

(2 ) (3.)(4.)

4 1. 2. 3. 4.

1) 2) 3)

1. (. ..)2. (. .. )3. (. ..)

48 () 68 69 70 (4) (5) (6)

( 57)1) 2 2) 3) 4) 5)

6) ( 54 ) [ 25 (.. 2537) ] ()

( 58)1) 2 2) 3)

( 59) (1) 2 (2)

(3) (4) (5) (56) ()

(1) (2) (3) (4) (5) (6) (7) (8) (9) (10)

.. 2510 ( 3) .. 2522 ( 5) .. 2530 4

...( 79)

( 79 )1) 2) 3)

1) 2 ) ) 2) 3 ) ) )

( 79) ) )

2 1. 2.

3 8.1.1 8.1.2 8.1.3

( 83)(1) (2) (3) (4) (5)

(New Drugs) (1) (New chemical entities) (New derivatives) (2) (New Indication) (3) / (New Combination) (4) (New delivery) (Bioavailability)

8.2.1 (Original products)8.2.2 (Generic products)

(Original products) 2 1. 2.

Original products (Original products) (Condition Approval)

Original products (1) (Protocol) 2 (2)

(3) (Unconditional Approval)

(Generic products) 3 1. (Bioequivalence)

2. 8.1.1 3.

1. 2.

3. 4. 5. 6.

3 1. 2. 3.

1. 2. 3.

3.1 3.2 3.3 3.4 3.5 3.6

2 ) ) 83

2 1. 2.

- - - - ()

1. 2. 3. 4. (Disintegration time)5. (Dissolution time)6. 7.

1. 2. 3. 2 1 1

- - Accreditation overseas suppliers FDA certificate of free sale-

- 1. 2. 3. 4.

11.

( 72)

(1) (2) (3) (4) (5)

(1) (2) 86

(1) (2)

( 85 )

12. ( 88)(1) (2) (3)

(4) (5) (6) (7) (8) 77

(9) (.89)(10) (.90) ( 88 ) (1) (4) (5) (6) (7) (8)

88 (1) ((2)

- - - - - - -

- - - - - ()

1. - - - - - - - -

2. - - - - 3. -